Dermatology to vascular Leveraging Ra Medical’s Pharos dermatology laser legacy to cross-sell into vascular spaces where excimer laser technology and catheter systems are already recognized, targeting clinics that treat both dermatological and vascular conditions.

Vertical integration Capitalizing on the full in-house manufacturing and ISO 13485 certified clean room capabilities in Carlsbad to offer turnkey supply for endovascular laser systems and single-use catheters, reducing procurement risk for hospital networks.

New leadership momentum Engaging with the current management team and Board including Executive Chairman with medtech pedigree to pursue strategic partnerships, private placements, or distributor networks that can accelerate market adoption of DABRA and LockeT products.

Expansion opportunities Target hospitals and vascular centers focusing on peripheral artery disease who can benefit from excimer laser-assisted declotting and channel creation, with a focus on minimally invasive solutions that improve limb perfusion and patient outcomes.

Financial and partnerships Position Ra Medical as a scalable, cash-efficient vendor for distributors and groups seeking innovative vascular devices, highlighting recent product launches, regulatory clearances, and potential for co-development or bundled offerings with complementary cardiovascular technologies.